VKH
LPCN icon

Virtu KCG Holdings’s Lipocine LPCN Stock Holding History

Virtu KCG Holdings’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,973
Closed -$131K – 3231
2017
Q1 		$131K Buy
1,973
+425
+27% +$27.5K ﹤0.01% 2590
2016
Q4 		$97K Buy
+1,548
New +$98K ﹤0.01% 2922
2016
Q3 		– Sell
-845
Closed -$44K – 3298
2016
Q2 		$44K Buy
+845
New +$131K ﹤0.01% 2699
2015
Q2 		– Sell
-823
Closed -$97K – 3566
2015
Q1 		$97K Buy
+823
New +$89.5K ﹤0.01% 2660
2014
Q4 		– Sell
-1,581
Closed -$162K – 4018
2014
Q3 		$162K Buy
+1,581
New +$197K ﹤0.01% 3030

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Virtu KCG Holdings's LPCN Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Lipocine (LPCN) in Q2 2017, closing a stake of 1,973 shares — an estimated $131K sold.

Virtu KCG Holdings first reported a position in LPCN in Q3 2014 and held it in 5 quarters. The position peaked at $162K in Q3 2014. 42 funds tracked by Wall St. Rank hold LPCN as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Lipocine position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,973 Lipocine shares in Q2 2017, an estimated $131K.
  • Virtu KCG Holdings first reported a position in Lipocine in Q3 2014 and held it in 5 quarters.
  • Virtu KCG Holdings's Lipocine position peaked at $162K in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Lipocine as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.